Pneumonia

exp date isn't null, but text field is

Pneumonia is an infection of the lung tissue caused by various bacteria, viruses or fungi. Identification of the causative organism and drug sensitivity testing is the key to correct treatment. However, because of the serious nature of the infection, antibiotic treatment should be started immediately based on knowledge of the most probable causative organism and the antibiotics used for its treatment.  Local knowledge of drug resistance patterns are also taken into account. Treatment may be maintained or changed based on culture results and assessment of the patient’s response to initial treatment. In the event that the cultures of blood or sputum prove negative, empiric treatment is continued with clinical response as a guide. 

The severity of the illness is a key factor in the decision for admission, and the choice of first or second-line treatment.  

Severity score for community acquired pneumonia (CURB-65)

Severity score may be based on the following, assigning one point to each of the following factors (maximum 5 points);

  • Confusion, restlessness, or excessive drowsiness
  • Blood Urea Nitrogen (>7 mmol/L)
  • Respiratory rate (≥ 30 per minute in adults, and ≥ 50 in children)
  • Low BP (Systolic BP < 90 and/or diastolic BP < 60 mmHg)
  • Patients at the extremes of age, (< 5yr or  ≥ 65yr)

 

Score 0-1; consider home treatment

Score 2-3; consider short inpatient hospitalisation

Score > 3; admit and consider intensive care

 

In the presence any of the following additional factors, all cases of pneumonia would warrant hospitalisation:

  • Coexisting diseases such as chronic lung disease, heart failure or renal disease
  • Extensive disease, multiple lobes involved
  • Low oxygen saturation SpO2, < 92% on room air
  • Severe tachycardia

Causes

Community acquired pneumonia

  • Streptococcus pneumonia
  • Streptococcus pyogenes
  • Haemophilus influenza
  • Klebsiella pneumoniae
  • Mycoplasma pneumonia and Legionella pneumophila (tend to occur in epidemics)
  • Staphylococcus aureus (in children after viral illness like measles, in diabetics or in the elderly during ‘flu’ epidemics)

Aspiration pneumonia

  • Anaerobic and/or gram negative organisms (associated with aspiration e.g. stroke, seizures, unconsciousness)

Hospital acquired pneumonia

  • Gram-negative bacteria e.g. Pseudomonas aeruginosa 
  • MRSA (Methicillin resistant) 
  • VRSA (Vancomycin resistant) 
  • Staphylococcus aureus 

Others

  • Pneumocystis jiroveci pneumonia and other fungi (in immunocompromised states e.g. haematological malignancies, HIV/AIDS)
  • Viruses

Symptoms

  • Fever - short history 
  • Productive cough 
  • Sputum - rusty or blood stained, yellowish, greenish
  • Pleuritic chest pain - worse on deep breathing or coughing
  • Breathlessness
  • Sweating
  • Muscle aches
  • Elderly and immunocompromised patients may have minimum or no symptoms

Signs

  • Rapid breathing 
  • Grunting (in children)
  • Use of accessory muscles of respiration and flaring of the nasal margins
  • Lower chest wall indrawing (in children)
  • Restricted movement of the affected side of the chest (due to pain)
  • Fever
  • Rapid pulse rate
  • Blood pressure may be normal or low
  • Signs of consolidation or pleural effusion on chest examination
  • Restlessness or confusion, drowsiness
  • Low blood oxygen saturation by pulse oximetry < 92%

Complications

  • Pleural effusion 
  • Lung abscess
  • Empyema
  • Pericardial effusion/pericarditis
  • Pneumothorax particularly Staph. aureus infection, Pneumocystis jiroveci pneumonia
  • Meningitis
  • Septicaemia with multi organ failure
  • Adult respiratory distress syndrome (ARDS)

Investigations

  • FBC
  • C-reactive protein (CRP)
  • Chest X-ray
  • Sputum gram stain and culture and sensitivity
  • Ziehl-Neelsen stain for acid-fast bacilli (to exclude TB)
  • Blood culture and sensitivity
  • Blood urea and electrolytes

Treatment

Treatment Objectives

  • To identify patients at greater risk who require in-hospital management 
  • To alleviate symptoms
  • To treat and eradicate the infection 
  • To prevent and/or manage complications 

Non-pharmacological treatment

  • Nurse in comfortable position, usually with head raised
  • Sponging to control fever, especially in children < 5 years (who are at risk of febrile convulsions)
  • Adequate oral hydration (if it can be tolerated)
  • Chest physiotherapy

Pharmacological Treatment 

Ambulatory patient: low severity score < 2 (see above)

 

Hospitalised patient: Severity score, ≥ 2 or with additional factors as mentioned above 

 

 

Referral Criteria

  • Refer to the paediatrician or physician specialist if no improvement occurs (i.e. fever remains high, patient is still breathless, or repeat X-rays  show complications or no resolution). 

Ambulatory patient: low severity score < 2 (see above)

1st Line Treatment

Evidence Rating: [A]

  • Amoxicillin (Amoxycillin), oral,

Adults

1 g 8 hourly for 7 days (high dose)

Children

5-12 years; 500 mg 8 hourly for 7 days

1-5 years; 250 mg 8 hourly for 7 days

6 months-1 year; 125 mg 8 hourly for 7 days

And

  • Azithromycin, oral,

Adult

500 mg daily for 6 days

Children

10 mg/kg daily for 6 days

Or  

  • Erythromycin, oral, (if patient is allergic to penicillin)

Adult

500 mg 6 hourly for 7 days

Children

8-18 years; 250-500 mg 6 hourly for 7 days

2-8 years; 250 mg 6 hourly for 7 days

6 months-2 years; 125 mg 6 hourly for 7 days

2nd Line Treatment

Evidence Rating: [A]

  • Cefuroxime, oral,

Adults

500 mg 12 hourly for 7 days

Children

3 months-12 years; 30 mg/kg/day in two divided doses for 7 days

> 12 years; 250-500 mg 12 hourly for 7 days

Or

  • Doxycycline, oral,

Adults

100 mg 12 hourly for 7-14 days depending on severity

Note: Not recommended in pregnancy, lactating mothers and in children < 8 years of age. 

Hospitalised patient: Severity score, ≥ 2 or with additional factors as mentioned above 

  • Oxygen, by face mask or nasal prongs,

Adults and Children 

Maintain oxygen saturation > 92%

And

  • IV fluids as normal saline and dextrose saline to replace estimated insensible loss

And

  • Paracetamol, oral,

Adults

500 mg-1g 6-8 hourly 

Children

6-12 years; 250-500 mg 6-8 hourly

1-5 years; 120-250 mg 6-8 hourly

3 months-1 year; 60-120 mg 6-8 hourly

Or

  • Paracetamol suppository

Adult and children doses as above

And 

  • Amoxicillin + Clavulanic Acid, IV, (change to oral route when patient improves)

Adults

1.2 g 8 hourly for 7-10 days

Children

3 months-18 years; 30 mg/kg 8 hourly, max. 1.2 g 8 hourly for  7-10 days

< 3 months; 30 mg/kg 12 hourly for 7-10 days

And

  • Azithromycin, oral,  

Adult

500 mg daily for 3-7 days

Children

10 mg/kg once daily for 3-7 days

Or

  • Azithromycin, IV,  

Adult

500 mg daily for 3 days 

Revert to oral azithromycin, when clinically stable to complete 7 days  of  treatment.  (See section on treatment for ambulatory patients above).  

Children

IV route not recommended in children for pneumonia treatment

Note: Azithromycin infusion should not be given in shorter than 1 hour. It should not be given as an IV bolus or as an intramuscular injection. 

2nd line treatment 

Evidence Rating: [A]

  • Ceftriaxone, IV,

Adult

2 g daily for 7-10 days

Children

All ages 25 mg/kg 12 hourly (max. 75 mg/kg daily)

And

  • Azithromycin, IV  (as above) 

Treatment for aspiration pneumonia

1st Line treatment 

Evidence Rating: [B]

  • Ceftriaxone, IV,

Adult

2 g daily for 7-10 days 

Children

All ages 50-75 mg/kg/day in divided 12 hourly doses 

Or

  • Amoxicillin + Clavulanic Acid, IV, (change to oral route when patient improves)

Adults

1.2 g 8 hourly for 7-10 days

Children

3 months-18 years; 30 mg/kg 8 hourly, max 1.2 g 8 hourly for  7-10 days

< 3 months; 30 mg/kg 12 hourly for 7-10 days

Or

  • Ciprofloxacin, IV, (to be administered over 60 minutes)

Adults

400 mg 8-12 hourly for 7 days 

Children

10 mg/kg (max. 400 mg) 12 hourly for 7 days

And

  • Metronidazole, IV,

Adults

500 mg 8 hourly for 7 days

Children

7.5 mg/kg 8 hourly for 7 days

Or

  • Clindamycin, IV,

Adults

300-600 mg 6 hourly for 7 days

Children

3-6 mg/kg 6 hourly for 7 days